Loss-of-function Mutations in TNFAIP3 Leading to A20 Haploinsufficiency Cause an Early-Onset Autoinflammatory Disease
Qing Zhou,Hongying Wang,Daniella M Schwartz,Monique Stoffels,Yong Hwan Park,Yuan Zhang,Dan Yang,Erkan Demirkaya,Masaki Takeuchi,Wanxia Li Tsai,Jonathan J Lyons,Xiaomin Yu,Claudia Ouyang,Celeste Chen,David T Chin,Kristien Zaal,Settara C Chandrasekharappa,Eric P Hanson,Zhen Yu,James C Mullikin,Sarfaraz A Hasni,Ingrid E Wertz,Amanda K Ombrello,Deborah L Stone,Patrycja Hoffmann,Anne Jones,Beverly K Barham,Helen L Leavis,Annet van Royen-Kerkof,Cailin Sibley,Ezgi D Batu,Ahmet Gül,Richard M Siegel,Manfred Boehm,Joshua D Milner,Seza Ozen,Massimo Gadina,JaeJin Chae,Ronald M Laxer,Daniel L Kastner,Ivona Aksentijevich
DOI: https://doi.org/10.1038/ng.3459
IF: 30.8
2015-01-01
Nature Genetics
Abstract:Systemic autoinflammatory diseases are driven by abnormal activation of innate immunity. Herein we describe a new disease caused by high-penetrance heterozygous germline mutations in TNFAIP3, which encodes the NF-κB regulatory protein A20, in six unrelated families with early-onset systemic inflammation. The disorder resembles Behçet's disease, which is typically considered a polygenic disorder with onset in early adulthood. A20 is a potent inhibitor of the NF-κB signaling pathway. Mutant, truncated A20 proteins are likely to act through haploinsufficiency because they do not exert a dominant-negative effect in overexpression experiments. Patient-derived cells show increased degradation of IκBα and nuclear translocation of the NF-κB p65 subunit together with increased expression of NF-κB-mediated proinflammatory cytokines. A20 restricts NF-κB signals via its deubiquitinase activity. In cells expressing mutant A20 protein, there is defective removal of Lys63-linked ubiquitin from TRAF6, NEMO and RIP1 after stimulation with tumor necrosis factor (TNF). NF-κB-dependent proinflammatory cytokines are potential therapeutic targets for the patients with this disease.